Risk factors for developing liver cancer in people with and without liver disease.

BACKGROUND:The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. MET...

Full description

Bibliographic Details
Main Authors: Jae Kyung Suh, Jayoun Lee, Jeong-Hoon Lee, Sangjin Shin, Ha Jin Tchoe, Jin-Won Kwon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6205612?pdf=render
id doaj-7d11bf1cba28448e9ac52f887287b277
record_format Article
spelling doaj-7d11bf1cba28448e9ac52f887287b2772020-11-25T01:52:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020637410.1371/journal.pone.0206374Risk factors for developing liver cancer in people with and without liver disease.Jae Kyung SuhJayoun LeeJeong-Hoon LeeSangjin ShinHa Jin TchoeJin-Won KwonBACKGROUND:The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. METHODS:This study used data from the National Health Insurance Service National Sample Cohort (NHIS-NSC) from 2002 to 2013. A retrospective matched cohort design was applied to compare the development of liver cancer in patients with and without liver disease. Cox- proportional hazard regression for liver cancer with competing risk of death was performed for all subjects or each group stratified according to age or income level. RESULTS:A total of 66,192 patients with liver disease and matched subjects without liver disease were included in the study. The incidences of liver cancer among patients with and without liver disease within a median 8-year follow-up period were 2.68% (n = 1,772) and 0.34% (n = 210), respectively. Cox- regression analysis for liver cancer incidence indicated that cirrhosis had the highest risk (hazard ratio [HR]: 18.13, 95% confidence interval [CI]: 15.24-21.58), followed by hepatitis B (HR: 9.32, 95% CI: 8.00-10.85). Subgroup analysis showed that the presence of liver disease was an important risk factor in younger as well as elderly people, and a higher risk of liver disease was also observed in the patients with Medicaid. CONCLUSIONS:Attention should be paid to the development of liver cancer in young people under 50 years old and preventive efforts to decrease the incidence of liver cancer among Medicaid recipients is needed.http://europepmc.org/articles/PMC6205612?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jae Kyung Suh
Jayoun Lee
Jeong-Hoon Lee
Sangjin Shin
Ha Jin Tchoe
Jin-Won Kwon
spellingShingle Jae Kyung Suh
Jayoun Lee
Jeong-Hoon Lee
Sangjin Shin
Ha Jin Tchoe
Jin-Won Kwon
Risk factors for developing liver cancer in people with and without liver disease.
PLoS ONE
author_facet Jae Kyung Suh
Jayoun Lee
Jeong-Hoon Lee
Sangjin Shin
Ha Jin Tchoe
Jin-Won Kwon
author_sort Jae Kyung Suh
title Risk factors for developing liver cancer in people with and without liver disease.
title_short Risk factors for developing liver cancer in people with and without liver disease.
title_full Risk factors for developing liver cancer in people with and without liver disease.
title_fullStr Risk factors for developing liver cancer in people with and without liver disease.
title_full_unstemmed Risk factors for developing liver cancer in people with and without liver disease.
title_sort risk factors for developing liver cancer in people with and without liver disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description BACKGROUND:The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. METHODS:This study used data from the National Health Insurance Service National Sample Cohort (NHIS-NSC) from 2002 to 2013. A retrospective matched cohort design was applied to compare the development of liver cancer in patients with and without liver disease. Cox- proportional hazard regression for liver cancer with competing risk of death was performed for all subjects or each group stratified according to age or income level. RESULTS:A total of 66,192 patients with liver disease and matched subjects without liver disease were included in the study. The incidences of liver cancer among patients with and without liver disease within a median 8-year follow-up period were 2.68% (n = 1,772) and 0.34% (n = 210), respectively. Cox- regression analysis for liver cancer incidence indicated that cirrhosis had the highest risk (hazard ratio [HR]: 18.13, 95% confidence interval [CI]: 15.24-21.58), followed by hepatitis B (HR: 9.32, 95% CI: 8.00-10.85). Subgroup analysis showed that the presence of liver disease was an important risk factor in younger as well as elderly people, and a higher risk of liver disease was also observed in the patients with Medicaid. CONCLUSIONS:Attention should be paid to the development of liver cancer in young people under 50 years old and preventive efforts to decrease the incidence of liver cancer among Medicaid recipients is needed.
url http://europepmc.org/articles/PMC6205612?pdf=render
work_keys_str_mv AT jaekyungsuh riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT jayounlee riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT jeonghoonlee riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT sangjinshin riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT hajintchoe riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT jinwonkwon riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
_version_ 1724992413870587904